As shown, PPARγ expression was higher in patients with dominant myeloblasts (M1 and M2 subtypes) compared to those with myelomonocytic cells (M4‐M5); on the other hand, AML cases with involvement of myelomonoblastic cells (M4) exhibited a higher level of PTEN mRNA. Here, PPARG is linked to acute myeloid leukemia.